Nested case-control study: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance. - Wikidata - wikimedia - TriplyDB

Nested case-control study: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance.

Nested case-control study: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance.

http://www.wikidata.org/entity/Q30152115

about

Removal of Integrated Hepatitis B Virus DNA Using CRISPR-Cas9.Review article: novel therapies for hepatitis B virus cure - advances and perspectives.Hepatitis B cure: From discovery to regulatory approval.Letter: hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma - authors' reply.Letter: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance - authors' reply.Letter: older age and male gender increase the risk of hepatocellular carcinoma after hepatitis B surface antigen (HBsAg) seroclearance.Letter: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance.Letter: hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma.

P2860

Q37714431-339B5338-D219-4166-8CDF-1A1A2117B1BC Q38865511-1E98A5B1-352A-4EFB-B618-CBB7847CE49B Q41952398-969F444F-B232-4547-A494-2180561894BC Q42388061-FF3D645C-A6EF-46EE-A354-D639487B4D41 Q43170475-9D8C6279-5F18-4036-8458-8A99737939D1 Q47615545-2044D68A-4F14-4686-A747-3BB8FDC2C06D Q47829977-DF270A7E-A3A4-4EE9-847D-93EF55DC925D Q50849376-E7D112E0-7762-491A-B93D-BE5C57C5262F

P2860

Nested case-control study: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance.

http://www.wikidata.org/entity/Q30152115

description

2016 nî lūn-bûn

@nan

2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Nested case-control study: hep ...... surface antigen seroclearance.

@ast

Nested case-control study: hep ...... surface antigen seroclearance.

@en

type

label

Nested case-control study: hep ...... surface antigen seroclearance.

@ast

Nested case-control study: hep ...... surface antigen seroclearance.

@en

prefLabel

Nested case-control study: hep ...... surface antigen seroclearance.

@ast

Nested case-control study: hep ...... surface antigen seroclearance.

@en

P1433

Q30152115-AE2824E6-A994-49F8-BAEF-A9791F02DB0A

P1476

Q30152115-1B441933-5838-4189-B8C5-3D3C2CE392C5

P2093

Q30152115-3AA3B2B2-24BC-466D-8EE2-232195114417

Q30152115-88CFEAE9-1823-4A71-8D5F-85FFB218E3D2

Q30152115-97B4182A-A15C-420C-96B5-BD9168F8F181

Q30152115-9CD8BA91-BA8C-46F9-A491-483454E5F767

Q30152115-9E0E6CA5-1065-4812-A60E-758741530D0A

Q30152115-B96813DB-3A9E-47BA-B7D8-5B296F953D02

Q30152115-F2771915-8C84-4FFE-BCD1-FDAB3BD9757E

P2860

Q30152115-05ACF6F7-AA4C-4AE3-B847-01BFA07C3836

Q30152115-09B400F5-C75D-4077-A57A-525CC874834B

Q30152115-0FC04617-5530-4DCB-B262-962F03BD700C

Q30152115-1BB3E6A1-D093-4957-867D-08AF09D87F03

Q30152115-226077D6-A3EB-4D71-B60A-7CED71EE1F2B

Q30152115-234CFC1B-31CB-48F1-8C9D-76715B569549

Q30152115-33F19A7E-AACD-4573-AD2D-5F1C11F178FF

Q30152115-46BEA8BA-72D1-47D3-A44D-2B0FB22A6E1B

Q30152115-4F1A4277-C513-4FBE-8DAC-13C199E5DBD2

Q30152115-5BA6E315-13BA-4705-AB5D-96B79B2F99F2

P304

Q30152115-5162CC90-F864-48A5-810D-A0A756287CF2

P31

Q30152115-7483A03D-DEE9-426E-AB03-2A2A38714D29

P356

Q30152115-EF96D8BA-AADD-42BC-BF9B-BB67508B9908

P407

Q30152115-4E3DB466-6494-4629-BF0C-11FBD6B90AA7

P433

Q30152115-233B9A20-3011-488B-BC6B-A7C680289DAB

P478

Q30152115-D6A5D170-9B7E-4A57-93F0-BAC8D18B8EB5

P577

Q30152115-A13F0442-4DDA-4D41-93A3-756EFD18EA49

P5875

Q30152115-020DF086-F395-46E1-A9EA-086F74849448

P698

Q30152115-C7299899-53D9-4BD4-AA8B-878804BB69C6

P932

Q30152115-D80E583B-6662-4FE5-AF83-16F96834B8B7

P356

P1433

Alimentary Pharmacology & Therapeutics

P1476

Nested case-control study: hep ...... surface antigen seroclearance.

@en

P2093

B C Simons

http://www.w3.org/2001/XMLSchema#string

B J McMahon

http://www.w3.org/2001/XMLSchema#string

L R Bulkow

http://www.w3.org/2001/XMLSchema#string

M Snowball

http://www.w3.org/2001/XMLSchema#string

P P Gounder

http://www.w3.org/2001/XMLSchema#string

P R Spradling

http://www.w3.org/2001/XMLSchema#string

S Negus

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hepatocellular carcinoma: An update

Chronic hepatitis B: update 2009

Relationship between level of hepatitis B virus DNA and liver disease: a population-based study of hepatitis B e antigen-negative persons with hepatitis B.

Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.

The Alaska Area Specimen Bank: a tribal-federal partnership to maintain and manage a resource for health research.

Synergistic effects of family history of hepatocellular carcinoma and hepatitis B virus infection on risk for incident hepatocellular carcinoma.

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan.

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.

Rates and risk factors for hepatitis B reactivation in a cohort of persons in the inactive phase of chronic hepatitis B-Alaska, 2001-2010.

The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B

P304

1197-1207

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/APT.13621

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

301218753

http://www.w3.org/2001/XMLSchema#string

P698

27061300

http://www.w3.org/2001/XMLSchema#string

P932

5053330

http://www.w3.org/2001/XMLSchema#string